• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of OE-recommended and posted health fraud internet site warning letters

Dictionary: The Office of Enforcement’s (OE) Health Fraud team is responsible for identifying firms engaging in internet health fraud and recommending Warning Letters. Warning Letter recommendations are sent to the Center for approval and then posted on FDA.gov. OE's Health Fraud team has been responsible for initiating approximately 15% of all Warning letters issued by FDA each year. We will measure the volume and success of OE’s health fraud surveillance work by the number of recommended warning letters and the resulting enforcement action.

Information is current as of February 12, 2013.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber of recommended WLs
Oct 2010N/A3
Nov 2010N/A3
Dec 2010N/A2
Jan 2011N/A2
Feb 2011N/A4
Mar 2011N/A2
Apr 2011N/A3
May 2011N/A1
Jun 2011N/A3
Jul 2011N/A3
Aug 2011N/A3
Sep 2011N/A3

FY 2011 Total: 32

Percent of OE-recommended health fraud internet site warning letters approved by the Center for issuance and posting on FDA.gov

Dictionary: The Office of Enforcement’s (OE) Health Fraud team is responsible for identifying firms engaging in internet health fraud and recommending Warning Letters. Warning Letter recommendations are sent to the Center for approval and then posted on FDA.gov. OE's Health Fraud team has been responsible for initiating approximately 15% of all Warning letters issued by FDA each year. We will measure the volume and success of OE’s health fraud surveillance work by the number of recommended warning letters and the resulting enforcement action.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercent
Oct 20101000
Nov 20101000
Dec 201010050
Jan 20111000
Feb 201110050
Mar 2011100100
Apr 2011100100
May 2011100100
Jun 20111000
Jul 20111000
Aug 2011100100
Sep 2011100100

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.